
Less butter, more plant oils, longer life?

Healthier planet, healthier people

Counting steps is good — is combining steps and heart rate better?

Appendix pain: Could it be appendicitis?

Can saw palmetto treat an enlarged prostate?

How does Ozempic work? Understanding GLP-1s for diabetes, weight loss, and beyond

Zinc: What it does for the body, and the best food sources

Respiratory health harms often follow flooding: Taking these steps can help

Tips to leverage neuroplasticity to maintain cognitive fitness as you age

Can white noise really help you sleep better?
Cancer Archive
Articles
Erectile dysfunction drugs not linked to melanoma
In the journals
The erectile dysfunction drugs collectively known as phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil (Viagra), may not cause melanoma, the most dangerous form of skin cancer, according to a study published online May 19, 2017, by the Journal of the National Cancer Institute.
In 2016, the FDA put PDE5 inhibitors on its watch list of medications with possible safety issues after some studies suggested they might increase the risk for melanoma. In response to the FDA's action, researchers analyzed data from five large-scale studies of the issue, involving 866,049 men, published between 2014 and 2016.
Factors that increase your risk for a secondary cancer
Several factors can make you more likely to develop a secondary cancer. Some are under your control. Others aren't. It's important for you to discuss your risks with your doctor and find out what you can do to lower your odds of developing cancer again. Equally important, discuss how often you need to get screened, so you can catch any new cancers early.
Childhood cancer. If you developed cancer before age 15, you'll need to stay on top of your health in the years to come. Some childhood tumors are caused by inherited syndromes that contribute to a lifelong increased risk for cancer. For example, Li-Fraumeni syndrome can lead to sarcoma, leukemia, and brain and breast cancers. The treatments you received to combat childhood cancer can also make you more vulnerable to future malignancies.
Combination hormonal therapy boosts survival in men with aggressive prostate cancer
The results of two studies found that using the drug abiraterone in combination with other hormonal therapy drugs to treat aggressive prostate cancer produced more favorable results than the first-line therapy alone.
The healing power of art
Creative activities can relieve stress, aid communication, and help arrest cognitive decline.
Image: © Katherine A. Gallagher Integrative Therapies Art Therapy Program at the Mass. General Cancer Center
The title of a recent documentary film, I Remember Better When I Paint, sums up the findings of a growing body of research into the cognitive effects of making art. The movie demonstrates how drawing and painting stimulated memories in people with dementia and enabled them to reconnect with the world. People with dementia aren't the only beneficiaries. Studies have shown that expressing themselves through art can help people with depression, anxiety, or cancer, too. And doing so has been linked to improved memory, reasoning, and resilience in healthy older people.
Antibiotic use linked to increased risk of precancerous colon polyps
Research we're watching
Recent evidence suggests that antibiotics, which affect the makeup of intestinal bacteria, might be associated with an increased risk of colorectal cancer. A team led by researchers from Harvard Medical School wanted to see if antibiotic use is also associated with adenomatous polyps, precursors of colon cancer that significantly increase the risk of developing the disease.
The team analyzed data from 16,642 women ages 60 or older participating in the Nurses' Health Study. They first looked at participants' antibiotic use from ages 20 through 59 and in the most recent four years. They also checked the results with the women's colonoscopies and found 1,195 cases of adenomatous polyps.
Being overweight any time in adulthood still associated with a shorter life
Research we're watching
Previous studies have suggested that being somewhat overweight or even slightly obese may not be associated with a shortened life span. Some studies have suggested that being a bit overweight might even be healthier than being at normal weight. This has been referred to as the "obesity paradox."
A recent analysis of data from the Nurses' Health Studies I and II and the Health Professionals Follow-up Study has helped bring clarity to this paradox. Researchers from the Harvard T.H. Chan School of Public Health and Boston University School of Public Health assessed the maximum body mass index (BMI) over 16 years for more than 190,000 postmenopausal women and 35,000 senior men. They then tracked who died over a follow-up period averaging 12 years. They found that people with a maximum BMI in the normal range (18.5 to 24.9 kg/m2) throughout life had the lowest risk of death. Those whose highest recorded BMI fell into the overweight or obese category were at elevated risk of dying from any cause, as well as dying specifically from cardiovascular disease, cancer, or respiratory disease, during the follow-up period.

Less butter, more plant oils, longer life?

Healthier planet, healthier people

Counting steps is good — is combining steps and heart rate better?

Appendix pain: Could it be appendicitis?

Can saw palmetto treat an enlarged prostate?

How does Ozempic work? Understanding GLP-1s for diabetes, weight loss, and beyond

Zinc: What it does for the body, and the best food sources

Respiratory health harms often follow flooding: Taking these steps can help

Tips to leverage neuroplasticity to maintain cognitive fitness as you age

Can white noise really help you sleep better?
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!
Sign Up